Dominant-positive HSF1 decreases alpha-synuclein level and alpha-synuclein-induced toxicity

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 1875-1881

  Liangliang, Xu ^a,b   Yonghui, Hou ^b   Shunmei, E ^b   Shoufang, Gong ^b   Wei, Zhou ^b   Jiangying, Zou ^b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

Alpha synuclein; Heat shock protein; HSF1; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; PLASMID DNA; DNA BINDING PROTEIN; HEAT SHOCK TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; CELL INCLUSION; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN TARGETING; SH SY5Y CELL; CHEMISTRY; DOMINANT GENE; DRUG EFFECT; GENETICS; METABOLISM; PROMOTER REGION; PROTEIN QUATERNARY STRUCTURE; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; CELL LINE, TUMOR; CYTOPROTECTION; DNA-BINDING PROTEINS; GENES, DOMINANT; HSP70 HEAT-SHOCK PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, QUATERNARY; TRANSCRIPTION FACTORS;

EID: 77953175438     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9623-2     Document Type: Article

References (30)

1. Eriksen JL, Dawson TM, Dickson DW, Petrucelli L (2003) Caught in the act: Alpha-synuclein is the culprit in Parkinson's disease. Neuron 40:453-456. doi:10.1016/S0896-6273(03) 00684-6
2. Mochizuki H, Yamada M, Mizuno Y (2006) Alpha-synuclein overexpression model. J Neural Transm Suppl 70:281-284. doi: 10.1007/978-3-211-45295-0-44
3. Zhou W, Hurlbert MS, Schaack J, Prasad KN, Freed CR (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon- derived cells. Brain Res 866:33-43. doi:10.1016/ S0006-8993(00)02215-0
4. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364:1167-1169. doi:10.1016/S0140- 6736(04)17103-1 (Pubitemid 39296604)
5. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson's disease. Science 302:841. doi:10.1126/ science.1090278
6. Dawson T, Mandir A, Lee M (2002) Animal models of PD: pieces of the same puzzle? Neuron 35:219-222. doi:10.1016/ S0896-6273(02)00780-8 (Pubitemid 34876725)
7. Feany MB, Bender WW (2000) A Drosophila model of Parkinson's disease. Nature 404:394-398. doi:10.1038/35006074 (Pubitemid 30164341)
8. Outeiro TF, Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302:1772-1775. doi:10.1126/science.1090439 (Pubitemid 37505742)
9. Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ (2004) Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem 279:25497-25502. doi:10.1074/jbc.M400255200 (Pubitemid 38756808)
10. McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, Ueda K, Breakefield XO, Hyman BT (2002) TorsinA and heat shock proteins act as molecular chaperones: Suppression of alpha-synuclein aggregation. J Neurochem 83:846-854. doi:10.1046/j. 1471-4159.2002.01190.x
11. Zourlidou A, Payne Smith MD, Latchman DS (2004) HSP27 but not HSP70 has a potent protective effect against alpha-synucleininduced cell death in mammalian neuronal cells. J Neurochem 88:1439-1448
12. McLean PJ, Klucken J, Shin Y, Hyman BT (2004) Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro. Biochem Biophys Res Commun 321:665-669. doi:10.1016/j.bbrc.2004.07.021 (Pubitemid 39127407)
13. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295:865-868. doi:10.1126/science.1067389 (Pubitemid 34118369)
14. Dedmon MM, Christodoulou J, Wilson MR, Dobson CM (2005) Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem 280:14733-14740. doi:10.1074/jbc.M413024200 (Pubitemid 40562821)
15. Voellmy R (2005) Dominant-positive and dominant-negative heat shock factors. Methods 35:199-207. doi:10.1016/j.ymeth. 2004.08.010
16. Wagstaff MJ, Smith J, Collaco-Moraes Y, de Belleroche JS, Voellmy R, Coffin RS, Latchman DS (1998) Delivery of a constitutively active form of the heat shock factor using a virus vector protects neuronal cells from thermal or ischaemic stress but not from apoptosis. Eur J NeuroSci 10:3343-3350. doi: 10.1046/j.1460-9568.1998.00339.x (Pubitemid 29074125)
17. Fujimoto M, Takaki E, Hayashi T, Kitaura Y, Tanaka Y, Inouye S, Nakai A (2005) Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J Biol Chem 280:34908-34916. doi:10.1074/jbc. M506288200 (Pubitemid 41504625)
18. McLean PJ, Kawamata H, Hyman BT (2001) Alpha-synucleinenhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104:901-912. doi:10.1016/S0306-4522(01)00113-0 (Pubitemid 32607439)
19. Auluck PK, Meulener MC, Bonini NM (2005) Mechanisms of suppression of {alpha}-synuclein neurotoxicity by geldanamycin in Drosophila. J Biol Chem 280:2873-2878. doi:10.1074/jbc. M412106200
20. Liu F, Nguyen JL, Hulleman JD, Li L, Rochet JC (2008) Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease. J Neurochem 105:2435-2453
21. Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Bjorklund A (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alphasynuclein in the nigrostriatal system. J Neurosci 22:2780-2791
22. Lee M, Hyun D, Halliwell B, Jenner P (2001) Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J Neurochem 76:998-1009. doi:10.1046/j. 1471-4159.2001.00149.x (Pubitemid 32167373)
23. Zhao DL, Zou LB, Zhou LF, Zhu P, Zhu HB (2007) A cell-based model of alpha-synucleinopathy for screening compounds with therapeutic potential of Parkinson's disease. Acta Pharmacol Sin 28:616-626. doi:10.1111/j.1745-7254. 2007.00539.x (Pubitemid 46684012)
24. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E (2000) Alphasynuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157:401-410
25. Hayashita-Kinoh H, Yamada M, Yokota T, Mizuno Y, Mochizuki H (2006) Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model. Biochem Biophys Res Commun 341:1088-1095. doi:10.1016/j.bbrc.2006.01.057 (Pubitemid 43221777)
26. Bukau B, Weissman J, Horwich A (2006) Molecular chaperones and protein quality control. Cell 125:443-451. doi:10.1016/j.cell. 2006.04.014
27. McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol 179:38-46. doi:10.1006/exnr.2002.8050 (Pubitemid 36062617)
28. Ding Q, Keller JN (2001) Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J Neurochem 77:1010-1017. doi:10.1046/j.1471-4159.2001.00302.x (Pubitemid 32467056)
29. Opazo F, Krenz A, Heermann S, Schulz JB, Falkenburger BH (2008) Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging. J Neurochem 106:529-540. doi:10.1111/j.1471-4159.2008.05407. x
30. Fan GH, Zhou HY, Yang H, Chen SD (2006) Heat shock proteins reduce alpha-synuclein aggregation induced by MPP ? in SK-NSH cells. FEBS Lett 580:3091-3098. doi:10.1016/j.febslet. 2006.04.057 (Pubitemid 43729666)